| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Jung-Joon Min | |
| Jin Hai Zheng | |||
| P2860 | cites work | Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs | Q50071115 |
| Development of a flexible and potent hypoxia-inducible promoter for tumor-targeted gene expression in attenuated Salmonella | Q50078763 | ||
| Combined therapy with flk1-based DNA vaccine and interleukin-12 results in enhanced antiangiogenic and antitumor effects | Q50092054 | ||
| Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium | Q50120814 | ||
| Combination bacteriolytic therapy for the treatment of experimental tumors | Q24555050 | ||
| The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas | Q24675936 | ||
| Exploiting tumour hypoxia in cancer treatment | Q28264146 | ||
| A DNA vaccine targeting survivin combines apoptosis with suppression of angiogenesis in lung tumor eradication | Q28306137 | ||
| Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in salmonella-infected macrophages | Q28594887 | ||
| Drug penetration in solid tumours | Q29614404 | ||
| New paradigm for tumor theranostic methodology using bacteria-based microrobot | Q30558192 | ||
| Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma | Q33340438 | ||
| Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapy | Q33731187 | ||
| Tumor-targeting bacterial therapy with amino acid auxotrophs of GFP-expressing Salmonella typhimurium | Q33756746 | ||
| Use of preferentially replicating bacteria for the treatment of cancer | Q33895307 | ||
| Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer | Q33925546 | ||
| Unraveling immune privilege | Q34290452 | ||
| Effective cancer vaccine platform based on attenuated salmonella and a type III secretion system | Q34438443 | ||
| Pancreatic cancer regression by intratumoural injection of live Streptococcus pyogenes in a syngeneic mouse model. | Q34585120 | ||
| Engineering and visualization of bacteria for targeting infarcted myocardium | Q34994526 | ||
| Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograft (PDOX) and cell line mouse models. | Q35067893 | ||
| High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action | Q35080142 | ||
| Quorum-sensing Salmonella selectively trigger protein expression within tumors | Q35212564 | ||
| Tumor-specifically hypoxia-induced therapy of SPRY1/2 displayed differential therapeutic efficacy for melanoma | Q35402529 | ||
| Antitumor effect of sFlt-1 gene therapy system mediated by Bifidobacterium Infantis on Lewis lung cancer in mice | Q35549844 | ||
| Tumor-targeting Salmonella typhimurium A1-R arrests growth of breast-cancer brain metastasis | Q35550049 | ||
| Tumor-Targeting Salmonella typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models | Q35654559 | ||
| Enhancement of anti-murine colon cancer immunity by fusion of a SARS fragment to a low-immunogenic carcinoembryonic antigen | Q35819268 | ||
| Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer | Q35840470 | ||
| Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model | Q35859997 | ||
| Obligate anaerobic Salmonella typhimurium strain YB1 treatment on xenograft tumor in immunocompetent mouse model | Q35871464 | ||
| Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth | Q35921725 | ||
| Salmonella-Based Therapy Targeting Indoleamine 2,3-Dioxygenase Coupled with Enzymatic Depletion of Tumor Hyaluronan Induces Complete Regression of Aggressive Pancreatic Tumors | Q36031608 | ||
| Tumor-targeting Salmonella typhimurium A1-R decoys quiescent cancer cells to cycle as visualized by FUCCI imaging and become sensitive to chemotherapy | Q36189385 | ||
| Salmonella typhimurium Suppresses Tumor Growth via the Pro-Inflammatory Cytokine Interleukin-1β. | Q36191597 | ||
| Attenuated mutant strain of Salmonella Typhimurium lacking the ZnuABC transporter contrasts tumor growth promoting anti-cancer immune response. | Q36232119 | ||
| Sensing and reacting to microbes through the inflammasomes | Q36253171 | ||
| Inhibitory effects of the attenuated Salmonella typhimurium containing the IL-2 gene on hepatic tumors in mice | Q36411334 | ||
| Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth | Q36476449 | ||
| Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo | Q40171422 | ||
| Endoglin (CD105) is a target for an oral DNA vaccine against breast cancer | Q40299665 | ||
| Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro | Q40318166 | ||
| Systemic administration of an attenuated, tumor-targeting Salmonella typhimurium to dogs with spontaneous neoplasia: phase I evaluation | Q40504400 | ||
| ppGpp-dependent stationary phase induction of genes on Salmonella pathogenicity island 1. | Q40552048 | ||
| Oral DNA vaccination: antigen uptake and presentation by dendritic cells elicits protective immunity | Q40762186 | ||
| Activation of inflammasome by attenuated Salmonella typhimurium in bacteria-mediated cancer therapy | Q40937873 | ||
| Enhancement of cancer vaccine therapy by systemic delivery of a tumor-targeting Salmonella-based STAT3 shRNA suppresses the growth of established melanoma tumors | Q41956511 | ||
| IL-18-producing Salmonella inhibit tumor growth | Q42000711 | ||
| Suicide gene/prodrug therapy using salmonella-mediated delivery of Escherichia coli purine nucleoside phosphorylase gene and 6-methoxypurine 2'-deoxyriboside in murine mammary carcinoma 4T1 model | Q42170767 | ||
| Continuous intravenous administration of live genetically modified salmonella typhimurium in patients with metastatic melanoma | Q43161957 | ||
| Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility | Q43615261 | ||
| Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice | Q43677697 | ||
| Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET) for diagnostic imaging. | Q43698668 | ||
| Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients | Q44591603 | ||
| Engineered Salmonella typhimurium expressing E7 fusion protein, derived from human papillomavirus, inhibits tumor growth in cervical tumor-bearing mice | Q44678997 | ||
| Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK. | Q45119720 | ||
| Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2'-deoxyriboside via Salmonella against murine tumors | Q45877024 | ||
| Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors | Q45882843 | ||
| Salmonella typhimurium A1-R tumor targeting in immunocompetent mice is enhanced by a traditional Chinese medicine herbal mixture. | Q45942575 | ||
| Immune response induced by Salmonella typhimurium defective in ppGpp synthesis | Q46852567 | ||
| The enhanced anti-angiogenic and antitumor effects of combining flk1-based DNA vaccine and IP-10. | Q47384264 | ||
| Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals | Q47794539 | ||
| Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo | Q47992263 | ||
| Tumor-targeting Salmonella typhimurium, a natural tool for activation of prodrug 6MePdR and their combination therapy in murine melanoma model | Q50025263 | ||
| Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis | Q50058791 | ||
| Recombinant Salmonella-based 4-1BBL vaccine enhances T cell immunity and inhibits the development of colorectal cancer in rats: in vivo effects of vaccine containing 4-1BBL. | Q36707828 | ||
| Hypoxia induces a phase transition within a kinase signaling network in cancer cells | Q36762646 | ||
| Inhibition of tumor growth using salmonella expressing Fas ligand | Q36812613 | ||
| Improving tumor targeting and therapeutic potential of Salmonella VNP20009 by displaying cell surface CEA-specific antibodies | Q36949433 | ||
| Plasmid-based Survivin shRNA and GRIM-19 carried by attenuated Salmonella suppresses tumor cell growth | Q37037539 | ||
| RGD Peptide Cell-Surface Display Enhances the Targeting and Therapeutic Efficacy of Attenuated Salmonella-mediated Cancer Therapy | Q37112974 | ||
| Engineering the perfect (bacterial) cancer therapy | Q37131536 | ||
| Salmonella typhimurium mediated delivery of Apoptin in human laryngeal cancer | Q37249330 | ||
| Engineering of bacteria for the visualization of targeted delivery of a cytolytic anticancer agent | Q37316867 | ||
| Delivery of the co-expression plasmid pEndo-Si-Stat3 by attenuated Salmonella serovar typhimurium for prostate cancer treatment | Q37416954 | ||
| Tumour-targeted delivery of TRAIL using Salmonella typhimurium enhances breast cancer survival in mice. | Q37424066 | ||
| Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium | Q37451801 | ||
| Targeted therapy via oral administration of attenuated Salmonella expression plasmid-vectored Stat3-shRNA cures orthotopically transplanted mouse HCC. | Q37478042 | ||
| Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo | Q37478104 | ||
| Systemic administration of attenuated Salmonella typhimurium in combination with interleukin-21 for cancer therapy | Q37560917 | ||
| Bacteriolytic therapy can generate a potent immune response against experimental tumors | Q37585498 | ||
| Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy. | Q38103859 | ||
| Noninvasive real-time imaging of tumors and metastases using tumor-targeting light-emitting Escherichia coli | Q38503600 | ||
| Combined prokaryotic-eukaryotic delivery and expression of therapeutic factors through a primed autocatalytic positive-feedback loop | Q38810736 | ||
| Enhancement of ovarian cancer chemotherapy by delivery of multidrug-resistance gene small interfering RNA using tumor targeting Salmonella | Q38942723 | ||
| Salmonella enterica serovar Typhimurium immunotherapy for B-cell lymphoma induces broad anti-tumour immunity with therapeutic effect | Q38994432 | ||
| Salmonella engineered to express CD20-targeting antibodies and a drug-converting enzyme can eradicate human lymphomas. | Q39143931 | ||
| Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfecting the attenuated Salmonella carrying a plasmid co-expressing p53 gene and mdm2 siRNA. | Q39145161 | ||
| Recombinant attenuated Salmonella typhimurium carrying a plasmid co-expressing ENDO-VEGI151 and survivin siRNA inhibits the growth of breast cancer in vivo | Q39195295 | ||
| Salmonella SL7207 application is the most effective DNA vaccine delivery method for successful tumor eradication in a murine model for neuroblastoma | Q39207345 | ||
| Antitumor effects of Stat3-siRNA and endostatin combined therapies, delivered by attenuated Salmonella, on orthotopically implanted hepatocarcinoma | Q39360242 | ||
| Therapeutic antitumor potential of endoglin-based DNA vaccine combined with immunomodulatory agents. | Q39365796 | ||
| Suppression of murine melanoma growth by a vaccine of attenuated Salmonella carrying heat shock protein 70 and Herpes simplex virus-thymidine kinase genes | Q39442058 | ||
| Salmonella-mediated tumor-targeting TRAIL gene therapy significantly suppresses melanoma growth in mouse model | Q39447947 | ||
| MTDH/AEG-1-based DNA vaccine suppresses lung metastasis and enhances chemosensitivity to doxorubicin in breast cancer | Q39576776 | ||
| Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer. | Q39623623 | ||
| Genetically engineered Salmonella typhimurium as an imageable therapeutic probe for cancer | Q39760012 | ||
| Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth | Q39960374 | ||
| Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy | Q39966345 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Salmonella Typhimurium | Q166491 |
| P304 | page(s) | 173-84 | |
| P577 | publication date | 2016-09-01 | |
| P1433 | published in | Chonnam Medical Journal | Q26842647 |
| P1476 | title | Targeted Cancer Therapy Using Engineered Salmonella typhimurium | |
| P478 | volume | 52 |
| Q91996390 | Bugs as Cancer Drugs: Challenges and Opportunities |
| Q54213329 | Endostatin gene therapy delivered by attenuated Salmonella typhimurium in murine tumor models. |
| Q57169602 | Increasing the bactofection capacity of a mammalian expression vector by removal of the f1 ori |
| Q47243767 | Molecular Methods to Analyze the Effect of Proteins Expressed by Salmonella During Its Intracellular Stage |
| Q92363011 | Novel Delivery Systems for Checkpoint Inhibitors |
| Q64073411 | Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy |
| Q49395392 | Salmonella Immunotherapy Improves the Outcome of CHOP Chemotherapy in Non-Hodgkin Lymphoma-Bearing Mice. |
| Q91743156 | Salmonella-Based Targeted Cancer Therapy: Updates on A Promising and Innovative Tumor Immunotherapeutic Strategy |
| Q90042170 | The bacterial instrument as a promising therapy for colon cancer |
| Q64897634 | Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities. |
| Q104280671 | Tweak to Treat: Reprograming Bacteria for Cancer Treatment |
Search more.